$HDSN
HUDSON TECHNOLOGIES INC /NY

2023 Q2 Form 10-Q Financial Statement

#000141057823000943 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $90.47M $77.20M
YoY Change -12.96% -8.46%
Cost Of Revenue $53.85M $46.87M
YoY Change 15.94% 21.68%
Gross Profit $36.63M $30.33M
YoY Change -36.3% -33.81%
Gross Profit Margin 40.48% 39.29%
Selling, General & Admin $8.273M $6.977M
YoY Change 17.95% 2.24%
% of Gross Profit 22.59% 23.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $699.0K $751.0K
YoY Change -53.02% -19.85%
% of Gross Profit 1.91% 2.48%
Operating Expenses $8.972M $7.675M
YoY Change 16.32% 2.03%
Operating Profit $27.66M $22.66M
YoY Change -44.45% -40.85%
Interest Expense -$1.899M $1.849M
YoY Change -172.4% -74.69%
% of Operating Profit -6.87% 8.16%
Other Income/Expense, Net
YoY Change
Pretax Income $25.76M $20.81M
YoY Change -45.39% -32.87%
Income Tax $6.567M $5.275M
% Of Pretax Income 25.5% 25.35%
Net Earnings $19.19M $15.53M
YoY Change -51.8% -47.45%
Net Earnings / Revenue 21.21% 20.12%
Basic Earnings Per Share $0.42 $0.34
Diluted Earnings Per Share $0.41 $0.33
COMMON SHARES
Basic Shares Outstanding 45.33M 45.33M
Diluted Shares Outstanding 47.30M 47.31M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.42M $12.32M
YoY Change -44.81% 139.17%
Cash & Equivalents $11.42M $12.32M
Short-Term Investments
Other Short-Term Assets $10.38M $6.726M
YoY Change 44.02% -12.42%
Inventory $134.4M $137.0M
Prepaid Expenses
Receivables $49.06M $38.76M
Other Receivables $0.00 $0.00
Total Short-Term Assets $205.3M $194.8M
YoY Change 7.88% 27.9%
LONG-TERM ASSETS
Property, Plant & Equipment $27.41M $20.23M
YoY Change 42.84% 5.45%
Goodwill $47.80M $47.80M
YoY Change 0.0% 0.0%
Intangibles $16.17M $16.87M
YoY Change -14.73% -14.21%
Long-Term Investments
YoY Change
Other Assets $2.386M $2.387M
YoY Change 245.8% 238.58%
Total Long-Term Assets $93.76M $95.00M
YoY Change -0.71% 0.51%
TOTAL ASSETS
Total Short-Term Assets $205.3M $194.8M
Total Long-Term Assets $93.76M $95.00M
Total Assets $299.1M $289.8M
YoY Change 5.03% 17.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.58M $15.16M
YoY Change 26.68% 75.76%
Accrued Expenses $31.76M $35.32M
YoY Change -17.76% 3.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $4.250M $4.250M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $53.59M $54.72M
YoY Change -5.56% 16.78%
LONG-TERM LIABILITIES
Long-Term Debt $25.09M $35.93M
YoY Change -68.91% -60.74%
Other Long-Term Liabilities $5.773M $6.062M
YoY Change -8.12% 4.18%
Total Long-Term Liabilities $30.86M $35.93M
YoY Change -61.75% -60.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.59M $54.72M
Total Long-Term Liabilities $30.86M $35.93M
Total Liabilities $87.61M $98.32M
YoY Change -39.08% -32.63%
SHAREHOLDERS EQUITY
Retained Earnings $92.70M $73.51M
YoY Change 293.73% -551.93%
Common Stock $454.0K $453.0K
YoY Change 0.89% 0.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $211.5M $191.5M
YoY Change
Total Liabilities & Shareholders Equity $299.1M $289.8M
YoY Change 5.03% 17.41%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $19.19M $15.53M
YoY Change -51.8% -47.45%
Depreciation, Depletion And Amortization $699.0K $751.0K
YoY Change -53.02% -19.85%
Cash From Operating Activities $10.58M $10.67M
YoY Change -63.27% 110.54%
INVESTING ACTIVITIES
Capital Expenditures $425.0K $412.0K
YoY Change -153.59% 1425.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$425.0K -$412.0K
YoY Change -46.41% 1425.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $3.263M
YoY Change -95.91%
Cash From Financing Activities -11.06M -3.227M
YoY Change -11.35% -4.5%
NET CHANGE
Cash From Operating Activities 10.58M 10.67M
Cash From Investing Activities -425.0K -412.0K
Cash From Financing Activities -11.06M -3.227M
Net Change In Cash -907.0K 7.027M
YoY Change -105.84% 323.31%
FREE CASH FLOW
Cash From Operating Activities $10.58M $10.67M
Capital Expenditures $425.0K $412.0K
Free Cash Flow $10.15M $10.25M
YoY Change -65.69% 103.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000925528
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45287619
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45328892
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P6M
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-13412
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3641539
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
300 Tice Boulevard
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 290
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Woodcliff Lake
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07677
CY2023Q1 dei City Area Code
CityAreaCode
845
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
735-6000
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
HDSN
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1660000
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45328892
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12322000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5295000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38764000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20872000
CY2023Q1 us-gaap Inventory Net
InventoryNet
137007000
CY2022Q4 us-gaap Inventory Net
InventoryNet
145377000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6726000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5289000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
194819000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
176833000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20229000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20568000
CY2023Q1 us-gaap Goodwill
Goodwill
47803000
CY2022Q4 us-gaap Goodwill
Goodwill
47803000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16866000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17564000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7713000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7339000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2387000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2386000
CY2023Q1 us-gaap Assets
Assets
289817000
CY2022Q4 us-gaap Assets
Assets
272493000
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
15156000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
14165000
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
32716000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
27908000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2599000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6303000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
4250000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4250000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
54721000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52626000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1601000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
244000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6062000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5763000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
35934000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38985000
CY2023Q1 us-gaap Liabilities
Liabilities
98318000
CY2022Q4 us-gaap Liabilities
Liabilities
97618000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45328892
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45287619
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
453000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
453000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
117535000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116442000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
73511000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
57980000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
191499000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
174875000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
289817000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
272493000
CY2023Q1 us-gaap Revenues
Revenues
77199000
CY2022Q1 us-gaap Revenues
Revenues
84338000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
46869000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
38518000
CY2023Q1 us-gaap Gross Profit
GrossProfit
30330000
CY2022Q1 us-gaap Gross Profit
GrossProfit
45820000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6977000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6824000
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
698000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
698000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
7675000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
7522000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
22655000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
38298000
CY2023Q1 us-gaap Interest Expense
InterestExpense
1849000
CY2022Q1 us-gaap Interest Expense
InterestExpense
7305000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20806000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30993000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5275000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1438000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15531000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29555000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45298514
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44779822
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47311027
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46736471
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000
CY2022Q1 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
72000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
403000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
29555000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
100896000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
174875000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
38000
CY2023Q1 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
2000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1057000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
15531000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
191499000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15531000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29555000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
751000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
937000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
698000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
698000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
322000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
-325000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
509000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
656000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1057000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
403000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
268000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
289000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4665000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1357000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
51000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18401000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24613000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8047000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6845000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1493000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1222000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3777000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1758000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1628000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10666000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5066000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
412000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-412000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27000
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
71000
CY2023Q1 hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-2000
CY2022Q1 hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-72000
CY2022Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
5186000
CY2022Q1 hdsn Payments Of Premiums To Extinguish Debt
PaymentsOfPremiumsToExtinguishDebt
3326000
CY2022Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-15000000
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3263000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
79866000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3227000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3379000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7027000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3492000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12322000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5152000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1369000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
2203000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
142000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 hdsn Percentage Of Stepdown From Baseline Levels Final Rule
PercentageOfStepdownFromBaselineLevelsFinalRule
0.10
CY2023Q1 hdsn Percentage Of Cumulative Reduction From Baseline Levels Subsequent Allowance
PercentageOfCumulativeReductionFromBaselineLevelsSubsequentAllowance
0.40
CY2023Q1 hdsn Allocation Allowance Received
AllocationAllowanceReceived
3000000
CY2023Q1 hdsn Allocation Allowance Received By Company As Percentage Of Hydrofluorocarbons Consumption
AllocationAllowanceReceivedByCompanyAsPercentageOfHydrofluorocarbonsConsumption
0.01
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company’s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer’s credit history before extending credit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the three month period ended March 31, 2023 there was one customer accounting for greater than 10% of the Company’s revenues and at March 31, 2023 there were $9.4 million of accounts receivable from this customer. For the three-month period ended March 31, 2022 there was no customer accounting for 10% of the Company’s revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</p>
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11600000
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 hdsn Cylinder Deposit Value
CylinderDepositValue
14400000
CY2022Q4 hdsn Cylinder Deposit Value
CylinderDepositValue
13600000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3500000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3500000
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1800000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15531000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29555000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45298514
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44779822
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2012513
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1956649
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47311027
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46736471
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
502568
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18483
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Estimates and Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Several of the Company’s accounting policies involve significant judgments, uncertainties, and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management’s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, goodwill and commitments and contingencies. With respect to trade accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrofluorocarbon (“HFC”) and hydrofluroolefin (‘HFO”) refrigerants and reclaimable, primarily hydrochlorofluorocarbons (“HCFC”), HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position. The process of sourcing refrigerants includes various procurement costs, such as freight, processing, insurance, and other costs, relating to the delivery of refrigerants. As a result of the recently noted global supply chain issues, the Company determined it could be exposed to incremental costs related to these refrigerant purchases. These costs represent the Company’s initial estimate that are possibly subject to finalization in future periods and are recorded in accrued expenses and other current liabilities on the consolidated balance sheet as of March 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</p>
CY2023Q1 us-gaap Depreciation
Depreciation
800000
CY2023Q1 us-gaap Inventory Gross
InventoryGross
144337000
CY2022Q4 us-gaap Inventory Gross
InventoryGross
152840000
CY2023Q1 us-gaap Inventory Adjustments
InventoryAdjustments
7330000
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
7463000
CY2023Q1 us-gaap Inventory Net
InventoryNet
137007000
CY2022Q4 us-gaap Inventory Net
InventoryNet
145377000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57817000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57405000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37588000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36837000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20229000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20568000
CY2022 us-gaap Depreciation
Depreciation
900000
CY2023Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1864000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2108000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1563000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1370000
CY2023Q1 hdsn Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2230000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9135000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1335000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7800000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1738000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6062000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7800000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M9D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0820
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
700000
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 us-gaap Goodwill
Goodwill
47800000
CY2022Q4 us-gaap Goodwill
Goodwill
47800000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16131000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16866000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15433000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17564000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
4329392
CY2023Q1 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Non Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonVested
1.10
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
381181
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
467301
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2610668
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y10M13D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.26
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17200000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20600000
CY2023Q1 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
0.0
CY2023Q1 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
0.0
CY2022Q4 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
1100000
CY2022Q4 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
1100000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
800000
CY2023Q1 hdsn Long Term Debt Current Net Of Other Debt.
LongTermDebtCurrentNetOfOtherDebt.
4250000
CY2022Q4 hdsn Long Term Debt Current Net Of Other Debt.
LongTermDebtCurrentNetOfOtherDebt.
4250000
CY2023Q1 us-gaap Debt Current
DebtCurrent
4250000
CY2022Q4 us-gaap Debt Current
DebtCurrent
4250000
CY2023Q1 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
24300000
CY2022Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
27563000
CY2023Q1 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
15000000
CY2022Q4 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
15000000
CY2023Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3366000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3578000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
35934000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38985000
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
40184000
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
43235000
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
90000000
CY2022Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.020
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
4250000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
4250000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
4250000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
30800000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
43550000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
hdsn-20230331_lab.xml Edgar Link unprocessable
0001410578-23-000943-index-headers.html Edgar Link pending
0001410578-23-000943-index.html Edgar Link pending
0001410578-23-000943.txt Edgar Link pending
0001410578-23-000943-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hdsn-20230331.xsd Edgar Link pending
hdsn-20230331x10q.htm Edgar Link pending
hdsn-20230331xex31d1.htm Edgar Link pending
hdsn-20230331xex31d2.htm Edgar Link pending
hdsn-20230331xex32d1.htm Edgar Link pending
hdsn-20230331xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
hdsn-20230331_cal.xml Edgar Link unprocessable
hdsn-20230331_def.xml Edgar Link unprocessable
hdsn-20230331_pre.xml Edgar Link unprocessable
hdsn-20230331x10q_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending